Congressional trading
Who in Congress traded AMGN?
Amgen Inc. - Common Stock · classified as Health care. 18 disclosed transactions across 12 members.
18
Transactions
12
Members
7 / 11
Buys / sells
3
Filed late
Committee overlap
3 of 12 members who traded AMGN sit on a committee with jurisdiction over Health care. This is a disclosed structural overlap, not evidence of wrongdoing. Nothing here asserts that any member acted on non-public information. Jurisdiction is mapped from published House and Senate committee rules — see the methodology.
Members
2 transactions
2 transactions
2 transactions1 filed past the 45-day deadline
2 transactions
2 transactionsCommittee overlap
2 transactions1 filed past the 45-day deadline
1 transactionCommittee overlap1 filed past the 45-day deadline- Sell2026-03-27$15,001 - $50,000disclosed after 116dfiling
1 transaction- Sell2025-12-03$1,001 - $15,000disclosed after 2dfiling
1 transactionCommittee overlap- Buy2025-06-06$1,001 - $15,000(Spouse)disclosed after 25dfiling
1 transaction- Buy2025-04-16$1,001 - $15,000(Dependent child)disclosed after 14dfiling
1 transaction- Sell2025-02-11$1,001 - $15,000(Spouse)disclosed after 0dfiling
1 transaction- Sell2025-01-06$1,001 - $15,000(Spouse)disclosed after 35dfiling
Where this comes from
13 transactions from House Clerk Periodic Transaction Reports and 5 from Senate eFD filings. Amounts are the statutory brackets filers report — Congress does not disclose exact values. Senate filings carry one filing date per report rather than per transaction, so “disclosed after” for a Senate row is measured to the date the whole report was filed. This page is a conflict-of-interest disclosure, not investment advice or a trading signal.